View Document Preview and Link Document Date: 2014-11-05 17:48:13 Open Document File Size: 222,00 KB Share Result on Facebook
City Cincinnati / / Company Administrator Intellectual Property Department Provider Synergies L.L.C. / Colony Stimulating Factors Review / Amgen / NCCN / Genzyme / Provider Synergies L.L.C. / CBC / Teva / GM / Magellan Medicaid Administration Inc. / / Continent Europe / / Country United States / / / Event FDA Phase / / IndustryTerm intermediate risk / treatment of neutropenia due to other hematopoietic disorders / treatment of patients with sickle cell disorders / Monitor for respiratory symptoms / imaging / / MedicalCondition X Acute Myeloid Peripheral Blood Leukemia / allergic reaction / neutrophil recovery neutropenia / headache / liver dysfunction / myelodysplastic syndrome / lung diseases / dysfunction / solid tumors / nausea / pericardial effusion / Thrombocytopenia / anaphylaxis / neuroblastoma / alopecia / hemoptysis / syncope / leukocytosis / cardiac arrhythmia / febrile neutropenia / pulmonary / capillary leak syndrome / peritonitis / tachycardia / hypersensitivity / anaphylactic reactions / infections / sepsis / wheezing / hypotension / arrhythmia / proteinuria / tumor / epistaxis / congestive heart failure / pneumonia / pulmonary infiltrates / congenital neutropenia / hypertension / Cancer / chemotherapy-induced neutropenia / petechiae / vasculitis / disease / flushing / arthralgia / latex allergies / dyspnea / Acute respiratory distress syndrome / hematuria / chronic / myeloid leukemia / Neutropenia / fever / sarcoma / vomiting / myelodysplasia / urticaria / allergic reactions / cardiac disease / osteoporosis / INDICATIONS Drug Manufacturer Cancer / infection / Splenic rupture / inflammation / pericardial effusions / rash / anemia / syndrome / disorders / respiratory distress / idiopathic neutropenia / cyclic neutropenia / / MedicalTreatment antibiotics / chemotherapy / radiotherapy / radiation / antibiotic therapy / / Organization Pharmacy and Therapeutics committee / American Society of Clinical Oncology / Therapeutics committee / FDA / Medicaid Agency / / Position physician / / Product cisplatin / Neupogen / Leukine / cyclophosphamide / Neulasta / etoposide / epinephrine / bacteriostatic water for injection / INDICATIONS Drug / Granix / / ProvinceOrState Ohio / ARDS / / Technology radiation / antibodies / transplantation / PHARMACOKINETICS / chemotherapy / recombinant DNA technology / / SocialTag 
Colony Stimulating Factors Therapeutic Class Review (TCR) May 22, 2014 No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording